Abstract
Oral squamous cell carcinoma (OSCC) is the leading cause of mortality in head and neck cancer. Unhealthy habits such as chewing tobacco, smoking, drinking, poor oral hygiene and diet are responsible for chronic inflammation and infections have been recognized as predisposing factors for oral carcinogenesis. Various bacterial species and viruses are known to be associated with oral cancer. The metabolic by-products of the bacterial flora induce permanent genetic alterations in epithelial cells of the host that may drive carcinogenesis. Recent advancements in “omics” technologies have been useful in identifying oral cancer-related microbiome, their genomes, virulence properties, and their interaction with host immunity. To understand the journey of a microbial community from supporting a healthy environment to transitioning into a diseased state, multi-omics approaches are being utilized. These approaches not only provide insight into the microbiome but they can also provide detailed information at the DNA (genome), RNA (transcriptome), protein (proteome), and metabolite (metabolome) level as well. The differential genomic and transcriptomic signatures would lead to the functional identity of the microbial community in a particular environment leading to alterations in the host biological process and pathways. The OMICS-based approaches are powerful tools available to researchers to understand the physiological and pathological roles of microbes in a host.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shakya M, Lo CC, Chain PSG (2019) Advances and challenges in metatranscriptomic analysis. Front Genet 10:904
Rosenberg E, Sharon G, Zilber-Rosenberg I (2009) The hologenome theory of evolution: a fusion of neo-Darwinism and Lamarckism. Environ Microbiol 11:2959–2962
Nyholm L, Koziol A, Marcos S, Botnen AB, Aizpurua O, Gopalakrishnan S et al (2020) Holo-omics: integrated host-microbiota multi-omics for basic and applied biological research. iScience 23(8):101414
Solbiati J, Frias-Lopez J (2018) Metatranscriptome of the oral microbiome in health and disease. J Dent Res 97(5):492–500
Filiatrault MJ (2011) Progress in prokaryotic transcriptomics. Curr Opin Microbiol 14(5):579–586
Bashiardes S, Zilberman-Schapira G, Elinav E (2016) Use of metatranscriptomics in microbiome research. Bioinformatics Biol Insights 10:19–25
Stashenko P, Yost S, Choi Y, Danciu T, Chen T, Yoganathan S et al (2019) The oral mouse microbiome promotes tumorigenesis in oral squamous cell carcinoma. mSystems 4(4):e00323–e00319
Loo CY, Mitrakul K, Voss IB, Hughes CV, Ganeshkumar N (2003) Involvement of an inducible fructose phosphotransferase operon in Streptococcus gordonii biofilm formation. J Bacteriol 185(21):6241–6254
Kilic AO, Tao L, Zhang Y, Lei Y, Khammanivong A, Herzberg MC (2004) Involvement of Streptococcus gordonii beta-glucoside metabolism systems in adhesion, biofilm formation, and in vivo gene expression. J Bacteriol 186(13):4246–4253
Janda WM, Kuramitsu HK (1978) Production of extracellular and cell-associated glucosyltransferase activity by Streptococcus mutans during growth on various carbon sources. Infect Immun 19(1):116–122
Rolla G, Oppermann RV, Waaler SM, Assev S (1981) Effect of aqueous solutions of sorbitol-xylitol on plaque metabolism and on growth of Streptococcus mutans. Scand J Dent Res 89(3):247–250
Duran-Pinedo AE, Chen T, Teles R, Starr JR, Wang X, Krishnan K et al (2014) Community-wide transcriptome of the oral microbiome in subjects with and without periodontitis. ISME J 8(8):1659–1672
Jorth P, Turner KH, Gumus P, Nizam N, Buduneli N, Whiteley M (2014) Metatranscriptomics of the human oral microbiome during health and disease. MBio 5(2):e01012–e01014
Yost S, Duran-Pinedo AE, Krishnan K, Frias-Lopez J (2017) Potassium is a key signal in host-microbiome dysbiosis in periodontitis. PLoS Pathog 13(6):e1006457
Yost S, Duran-Pinedo AE, Teles R, Krishnan K, Frias-Lopez J (2015) Functional signatures of oral dysbiosis during periodontitis progression revealed by microbial metatranscriptome analysis. Genome Med 7(1):27
Yost S, Stashenko P, Choi Y, Kukuruzinska M, Genco CA, Salama A et al (2018) Increased virulence of the oral microbiome in oral squamous cell carcinoma revealed by metatranscriptome analyses. Int J Oral Sci 10(4):32
Wilmes P, Bond PL (2004) The application of two-dimensional polyacrylamide gel electrophoresis and downstream analyses to a mixed community of prokaryotic microorganisms. Environ Microbiol 6(9):911–920
Salvato F, Hettich RL, Kleiner M (2021) Five key aspects of metaproteomics as a tool to understand functional interactions in host-associated microbiomes. PLoS Pathog 17(2):e1009245
Bhardwaj A, Kaur J, Wuest M, Wuest F (2017) In situ click chemistry generation of cyclooxygenase-2 inhibitors. Nat Commun 8(1):1
Kleiner M (2019) Metaproteomics: much more than measuring gene expression in microbial communities. mSystems 4(3):e00115–e00119
Lassek C, Burghartz M, Chaves-Moreno D, Otto A, Hentschker C, Fuchs S et al (2015) A metaproteomics approach to elucidate host and pathogen protein expression during catheter-associated urinary tract infections (CAUTIs). Mol Cell Proteomics 14(4):989–1008
Patnode ML, Beller ZW, Han ND, Cheng J, Peters SL, Terrapon N et al (2019) Interspecies competition impacts targeted manipulation of human gut bacteria by fiber-derived glycans. Cell 179(1):59–73. e13
Pathak KV, McGilvrey MI, Hu CK, Garcia-Mansfield K, Lewandoski K, Eftekhari Z et al (2020) Molecular profiling of innate immune response mechanisms in ventilator-associated pneumonia. Mol Cell Proteomics 19(10):1688–1705
Belda-Ferre P, Williamson J, Simon-Soro A, Artacho A, Jensen ON, Mira A (2015) The human oral metaproteome reveals potential biomarkers for caries disease. Proteomics 15(20):3497–3507
Gavin PG, Mullaney JA, Loo D, Cao KL, Gottlieb PA, Hill MM et al (2018) Intestinal metaproteomics reveals host-microbiota interactions in subjects at risk for Type 1 diabetes. Diabetes Care 41(10):2178–2186
Tanca A, Palomba A, Fraumene C, Manghina V, Silverman M, Uzzau S (2018) Clostridial butyrate biosynthesis enzymes are significantly depleted in the gut microbiota of nonobese diabetic mice. mSphere 24:3(5)
Jewett A, Head C, Cacalano NA (2006) Emerging mechanisms of immunosuppression in oral cancers. J Dent Res 85(12):1061–1073
Shah NG, Trivedi TI, Tankshali RA, Goswami JA, Jetly DH, Kobawala TP et al (2006) Stat3 expression in oral squamous cell carcinoma: association with clinicopathological parameters and survival. Int J Biol Markers 21(3):175–183
Squarize CH, Castilho RM, Sriuranpong V, Pinto DS Jr, Gutkind JS (2006) Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma. Neoplasia 8(9):733–746
Basseres DS, Baldwin AS (2006) Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25(51):6817–6830
Jin DY, Chae HZ, Rhee SG, Jeang KT (1997) Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. J Biol Chem 272(49):30952–30961
Lo WY, Tsai MH, Tsai Y, Hua CH, Tsai FJ, Huang SY et al (2007) Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin Chim Acta 376(1–2):101–107
Nakashima T, Yasumatsu R, Kuratomi Y, Masuda M, Kuwano T, Toh S et al (2006) Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma. Head Neck 28(1):24–30
Imai Y, Sasaki T, Shinagawa Y, Akimoto K, Fujibayashi T (2002) Expression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significance. Oral Oncol 38(6):557–561
Do Kyung K, Ahn SG, Park JC, Kanai Y, Endou H, Yoon JH (2004) Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in oral squamous cell carcinoma and its precusor lesions. Anticancer Res 24(3A):1671–1676
Schrijvers AH, Gerretsen M, Fritz JM, van Walsum M, Quak JJ, Snow GB et al (1991) Evidence for a role of the monoclonal antibody E48 defined antigen in cell-cell adhesion in squamous epithelia and head and neck squamous cell carcinoma. Exp Cell Res 196(2):264–269
Kusukawa J, Ryu F, Kameyama T, Mekada E (2001) Reduced expression of CD9 in oral squamous cell carcinoma: CD9 expression inversely related to high prevalence of lymph node metastasis. J Oral Pathol Med 30(2):73–79
Nakashima K, Shimada H, Ochiai T, Kuboshima M, Kuroiwa N, Okazumi S et al (2004) Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int J Cancer 112(6):1029–1035
Jagtap P, McGowan T, Bandhakavi S, Tu ZJ, Seymour S, Griffin TJ et al (2012) Deep metaproteomic analysis of human salivary supernatant. Proteomics 12(7):992–1001
Rudney JD, Xie H, Rhodus NL, Ondrey FG, Griffin TJ (2010) A metaproteomic analysis of the human salivary microbiota by three-dimensional peptide fractionation and tandem mass spectrometry. Mol Oral Microbiol 25(1):38–49
Kolmeder CA, de Vos WM (2014) Metaproteomics of our microbiome - developing insight in function and activity in man and model systems. J Proteomics 31(97):3–16
Heintz-Buschart A, May P, Laczny CC, Lebrun LA, Bellora C, Krishna A et al (2016) Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes. Nat Microbiol 2:16180
Broberg M, Doonan J, Mundt F, Denman S, McDonald JE (2018) Integrated multi-omic analysis of host-microbiota interactions in acute oak decline. Microbiome 6(1):21
Roy A, Wang S, Meschede-Krasa B, Breffle J, Van Hooser SD (2020) An early phase of instructive plasticity before the typical onset of sensory experience. Nat Commun 11(1):11
Washio J, Takahashi N (2016) Metabolomic studies of oral biofilm, oral cancer, and beyond. Int J Mol Sci 2:17(6)
Bultman SJ (2014) Emerging roles of the microbiome in cancer. Carcinogenesis 35(2):249–255
Wang Y, Zhou Y, Xiao X, Zheng J, Zhou H (2020) Metaproteomics: a strategy to study the taxonomy and functionality of the gut microbiota. J Proteomics 15(219):103737
Takahashi N (2015) Oral microbiome metabolism: from “who are they?” to “what are they doing?”. J Dent Res 94(12):1628–1637
Keyes PH (1968) Research in dental caries. J Am Dent Assoc 76(6):1357–1373
Helgeland K (1984) Inhibitory effect of NH4Cl on secretion of collagen in human gingival fibroblasts. Scand J Dent Res 92(5):419–425
Kurita-Ochiai T, Seto S, Suzuki N, Yamamoto M, Otsuka K, Abe K et al (2008) Butyric acid induces apoptosis in inflamed fibroblasts. J Dent Res 87(1):51–55
Yaegaki K, Qian W, Murata T, Imai T, Sato T, Tanaka T et al (2008) Oral malodorous compound causes apoptosis and genomic DNA damage in human gingival fibroblasts. J Periodontal Res 43(4):391–399
Warburg O (1956) On the origin of cancer cells. Science 123(3191):309–314
Takahashi N, Washio J, Mayanagi G (2010) Metabolomics of supragingival plaque and oral bacteria. J Dent Res 89(12):1383–1388
Ogawa T, Washio J, Takahashi T, Echigo S, Takahashi N (2014) Glucose and glutamine metabolism in oral squamous cell carcinoma: insight from a quantitative metabolomic approach. Oral Surg Oral Med Oral Pathol Oral Radiol 118(2):218–225
Humphrey SP, Williamson RT (2001) A review of saliva: normal composition, flow, and function. J Prosthet Dent 85(2):162–169
Carpenter GH (2013) The secretion, components, and properties of saliva. Annu Rev Food Sci Technol 4:267–276
Cuevas-Cordoba B, Santiago-Garcia J (2014) Saliva: a fluid of study for OMICS. Omics 18(2):87–97
Plottel CS, Blaser MJ (2011) Microbiome and malignancy. Cell Host Microbe 10(4):324–335
Larrosa M, Gonzalez-Sarrias A, Garcia-Conesa MT, Tomas-Barberan FA, Espin JC (2006) Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J Agric Food Chem 54(5):1611–1620
Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM (2005) The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med 3:27
Gong HL, Shi Y, Zhou L, Wu CP, Cao PY, Tao L et al (2013) The composition of microbiome in larynx and the throat biodiversity between laryngeal squamous cell carcinoma patients and control population. PLoS One 8(6):e66476
Wei J, Xie G, Zhou Z, Shi P, Qiu Y, Zheng X et al (2011) Salivary metabolite signatures of oral cancer and leukoplakia. Int J Cancer 129(9):2207–2217
Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M (2010) Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 6(1):78–95
Gerner EW, Meyskens FL Jr (2004) Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 4(10):781–792
Almadori G, Bussu F, Galli J, Limongelli A, Persichilli S, Zappacosta B et al (2007) Salivary glutathione and uric acid levels in patients with head and neck squamous cell carcinoma. Head Neck 29(7):648–654
El-Sayed S, Bezabeh T, Odlum O, Patel R, Ahing S, MacDonald K et al (2002) An ex vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region. Head Neck 24(8):766–772
Somashekar BS, Kamarajan P, Danciu T, Kapila YL, Chinnaiyan AM, Rajendiran TM et al (2011) Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues. J Proteome Res 10(11):5232–5241
Tripathi P, Kamarajan P, Somashekar BS, MacKinnon N, Chinnaiyan AM, Kapila YL et al (2012) Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target. Int J Biochem Cell Biol 44(11):1852–1861
Granato DC, Neves LX, Trino LD, Carnielli CM, Lopes AFB, Yokoo S et al (2021) Meta-omics analysis indicates the saliva microbiome and its proteins associated with the prognosis of oral cancer patients. Biochim Biophys Acta Proteins Proteomics 1869(8):140659
Haiser HJ, Turnbaugh PJ (2012) Is it time for a metagenomic basis of therapeutics? Science 336(6086):1253–1255
Nicholson JK, Holmes E, Wilson ID (2005) Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol 3(5):431–438
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Khan, S., Sinha, R., Dixit, A. (2022). Microbial “OMICS” in Oral Cancer. In: Routray, S. (eds) Microbes and Oral Squamous Cell Carcinoma. Springer, Singapore. https://doi.org/10.1007/978-981-19-0592-6_12
Download citation
DOI: https://doi.org/10.1007/978-981-19-0592-6_12
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-0591-9
Online ISBN: 978-981-19-0592-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)